| Back to the wild world of biotech again ... today I look at a teaser pitch from the Biotech Millionaire service over at Mauldin Economics -- they're hinting at a stock whose drug has some regenerative power, and which has both a big-market potential (in stroke) and a near-term possible hype story as they engage in clinical trials with COVID-19 patients. So what's the story? Just click below to... |
